Biomarker research, cannabis use tops March neurology coverage
Click Here to Manage Email Alerts
Research into biomarkers to identify concussion and differentiate ischemic stroke from intracerebral hemorrhage topped Healio Neurology’s coverage in March. Plus: cannabis use, neuroplasticity after stroke and Lewy body dementia.
Q&A: Researchers identify concussion biomarkers in saliva
A large prospective observational study examining non-invasive biomarkers identified unique indicators of concussion in the saliva of adult male athletes, according to results published in British Journal of Sports Medicine. Read more.
Cannabis use affects rate of medication overuse headache in patients with migraine
Cannabis use "significantly contributes" to the prevalence of medication overuse headache among patients with chronic migraine, according to study results scheduled for presentation at the American Academy of Neurology Annual Meeting. Read more.
Three-biomarker panel differentiates ischemic stroke from intracerebral hemorrhage
A biomarker panel with retinol binding protein 4, N-terminal pro B-type natriuretic peptide and glial fibrillary acid protein discerned ischemic stroke from intracerebral hemorrhage with modest accuracy, researchers reported in Neurology. Read more.
Q&A: Neuroplasticity after stroke reveals ‘critical’ early period for rehabilitation
A longitudinal study quantifying neuroplasticity in the ipsilesional and contralesional human motor cortex following a stroke demonstrated “a period of enhanced synaptic plasticity” that was strongest about 2 weeks after the event. Read more.
Study highlights ‘complex genetic architecture’ of Lewy body dementia
A genome-wide analysis of patients with Lewy body dementia and healthy controls identified five independent risk loci associated with Lewy body dementia, according to findings published in Nature Genetics. Read more.
Follow us on Twitter @HealioNeurology to stay up to date on all the latest news in the field.